SPCs in EU accession states must be backed by national authorisations
This article was originally published in Scrip
Executive Summary
European Court of Justice advocate general Yves Bot has sought to offer clarification for granting supplementary protection certificates (SPCs) in European Union accession countries. In his opinion on Kirin Amgen v State Patent Bureau of the Republic of Lithuania, the advocate general concluded that a patent holder of a centrally authorised medicinal product is prohibited from obtaining an SPC post-accession in Lithuania.